Previous Article | Next Article ![]()
Molecular and Cellular Biology, November 2007, p. 7865-7870, Vol. 27, No. 22
0270-7306/07/$08.00+0 doi:10.1128/MCB.00397-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.
,
Huiping Ling,1
Edwin R. Smith,2,
and
John C. Lucchesi1*
Department of Biology,1 Department of Cell Biology, Emory University, Atlanta, Georgia 303222
Received 6 March 2007/ Returned for modification 10 April 2007/ Accepted 31 August 2007
Dosage compensation refers to the equalization of most X-linked gene products between males, which have one X chromosome and a single dose of X-linked genes, and females, which have two X's and two doses of such genes. We developed a plasmid-based model of dosage compensation that allows new experimental approaches for the study of this regulatory mechanism. In Drosophila melanogaster, an enhanced rate of transcription of the X chromosome in males is dependent upon the presence of histone H4 acetylated at lysine 16. This chromatin mark occurs throughout active transcriptional units, leading us to the conclusion that the enhanced level of transcription is achieved through an enhanced rate of RNA polymerase elongation. We used the plasmid model to demonstrate that enhancement in the level of transcription does not depend on other histone marks and factors that have been associated with the process of elongation, thereby highlighting the special role played by histone H4 acetylated at lysine 16 in this process.
Published ahead of print on 17 September 2007.
Supplemental material for this article may be found at http://mcb.asm.org/.
Present address: Cancer Research Center of Hawaii, Honolulu, HI 96813.
Present address: Stowers Institute for Medical Research, Kansas City, MO 64110.
This article has been cited by other articles:
Copyright © 2010 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»